Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
B. Liahnna Stanley & Ambar Basu. (2023) ‘Chemical jail’: culture-centered theorizing of carcerality in methadone maintenance treatment and addiction recovery in the United States. Journal of Applied Communication Research 0:0, pages 1-18.
Read now
Read now
Ali Cheetham, Louisa Picco, Anthony Barnett, Dan I Lubman & Suzanne Nielsen. (2022) The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy. Substance Abuse and Rehabilitation 13, pages 1-12.
Read now
Read now
Paula Mayock & Shane Butler. (2022) “I’m always hiding and ducking and diving”: the stigma of growing older on methadone. Drugs: Education, Prevention and Policy 29:2, pages 139-149.
Read now
Read now
Erin Fanning Madden, Suzanne Prevedel, Timothy Light & Sandra H. Sulzer. (2021) Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review. Substance Use & Misuse 56:14, pages 2181-2201.
Read now
Read now
V. W. L. Tsang, K. Papamihali, A. Crabtree & J. A. Buxton. (2021) Acceptability of technological solutions for overdose monitoring: Perspectives of people who use drugs. Substance Abuse 42:3, pages 284-293.
Read now
Read now
Emmy Kageha Igonya, Andrew Guise, James Ndimbii, Fredrick Owiti, Tim Rhodes & Stephanie Strathdee. (2021) ‘Sometimes I feel like the other life on heroin was better’: transitioning experiences towards methadone, and HIV prevention implications in Urban Kenya. Drugs: Education, Prevention and Policy 28:3, pages 246-254.
Read now
Read now
Helen Phillips-Jackson, Clive Hallam, Niamh Cullen, Terry Pearson, Mark Gilman, Li Li & Paul Musgrave. (2020) Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements. ClinicoEconomics and Outcomes Research 12, pages 233-240.
Read now
Read now
Kevin Wombacher, Sarah E. Sheff & Natalie Itrich. (2020) Social Support for Active Substance Users: A Content Analysis of r/Drugs. Health Communication 35:6, pages 756-765.
Read now
Read now
Ditte Andersen & Malene Lue Kessing. (2019) Stigma, problem drug use, and welfare state encounters: changing contours of stigmatization in the era of social investment. Addiction Research & Theory 27:4, pages 277-284.
Read now
Read now
Adrian Carter, Michael Savic & Cynthia Forlini. (2018) Surveillance Medicine in the DigitalEra: Lessons From Addiction Treatment. The American Journal of Bioethics 18:9, pages 58-60.
Read now
Read now
Katherine Nieweglowski, Patrick W. Corrigan, Tri Tyas, Anastasia Tooley, Rachel Dubke, Juana Lara, Lorenzo Washington, Janis Sayer & Lindsay Sheehan. (2018) Exploring the public stigma of substance use disorder through community-based participatory research. Addiction Research & Theory 26:4, pages 323-329.
Read now
Read now
Sarah E. Wakeman & Josiah D. Rich. (2018) Barriers to Medications for Addiction Treatment: How Stigma Kills. Substance Use & Misuse 53:2, pages 330-333.
Read now
Read now
Karen McElrath. (2018) Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary. Substance Use & Misuse 53:2, pages 334-343.
Read now
Read now
Sean D. Young & Keith Heinzerling. (2017) The Harnessing Online Peer Education (HOPE) intervention for reducing prescription drug abuse: A qualitative study. Journal of Substance Use 22:6, pages 592-596.
Read now
Read now
Jazmín Mora-Ríos, Miriam Ortega-Ortega & Maria Elena Medina-Mora. (2017) Addiction-Related Stigma and Discrimination: A Qualitative Study in Treatment Centers in Mexico City. Substance Use & Misuse 52:5, pages 594-603.
Read now
Read now
Marika Augutis, David Rosenberg & Helene Hillborg. (2016) The Meaning of Work: Perceptions of Employed Persons Attending Maintenance Treatment for Opiate Addiction. Journal of Social Work Practice in the Addictions 16:4, pages 385-402.
Read now
Read now
Rachel M. Burns, Rosalie L. Pacula, Sebastian Bauhoff, Adam J. Gordon, Hollie Hendrikson, Douglas L. Leslie & Bradley D. Stein. (2016) Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013. Substance Abuse 37:1, pages 63-69.
Read now
Read now
Nick Doukas. (2014) Are Methadone Counselors Properly Equipped to Meet the Palliative Care Needs of Older Adults in Methadone Maintenance Treatment? Implications for Training. Journal of Social Work in End-of-Life & Palliative Care 10:2, pages 186-204.
Read now
Read now
Charlie Lloyd. (2013) The stigmatization of problem drug users: A narrative literature review. Drugs: Education, Prevention and Policy 20:2, pages 85-95.
Read now
Read now
Brian
E. Bride, Amanda
J. Abraham, Sara Kintzle & Paul
M. Roman. (2013) Social Workers' Knowledge and Perceptions of Effectiveness and Acceptability of Medication Assisted Treatment of Substance Use Disorders. Social Work in Health Care 52:1, pages 43-58.
Read now
Read now
Nick Doukas. (2011) Perceived barriers to identity transformation for people who are prescribed methadone. Addiction Research & Theory 19:5, pages 408-415.
Read now
Read now
Nick Doukas. (2011) Older Adults in Methadone Maintenance Treatment: A Literature Review. Journal of Social Work Practice in the Addictions 11:3, pages 230-244.
Read now
Read now
DanielZ. Buchman, Wayne Skinner & Judy Illes. (2010) Negotiating the Relationship Between Addiction, Ethics, and Brain Science. AJOB Neuroscience 1:1, pages 36-45.
Read now
Read now
Articles from other publishers (86)
Chien Ying Teo, Xin Er Yaw, Yi Ling Kum, Ee Vy Chia, Wei Shan Heng, Tahir Mehmood Khan & Pui San Saw. (2023)
Pharmacists' perceived barriers and facilitators as immunisers: Mapping
COM‐B
model to support intervention development
. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.
Crossref
Crossref
Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Inge Mick & Annette Binder. (2023) Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities. Harm Reduction Journal 20:1.
Crossref
Crossref
Anne C. Krendl & Brea L. Perry. (2023) Stigma Toward Substance Dependence: Causes, Consequences, and Potential Interventions. Psychological Science in the Public Interest.
Crossref
Crossref
Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter & Eugenia Oviedo-Joekes. (2023) The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review. Substance Abuse Treatment, Prevention, and Policy 18:1.
Crossref
Crossref
Alison Adams, Sarin Blawatt, Scott MacDonald, Rhys Finnick, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter & Eugenia Oviedo-Joekes. (2023) Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review. International Journal of Drug Policy 117, pages 104058.
Crossref
Crossref
Rune Ellefsen, Linda Elise Couëssurel Wüsthoff & Espen Ajo Arnevik. (2023) Patients’ satisfaction with heroin-assisted treatment: a qualitative study. Harm Reduction Journal 20:1.
Crossref
Crossref
Sugy Choi, Megan A. O’Grady, Charles M. Cleland, Elizabeth Knopf, Sueun Hong, Thomas D’Aunno, Yuhua Bao, Kelly S. Ramsey & Charles J. Neighbors. (2023) Clinics Optimizing MEthadone Take-homes for opioid use disorder (COMET): Protocol for a stepped-wedge randomized trial to facilitate clinic level changes. PLOS ONE 18:6, pages e0286859.
Crossref
Crossref
Leanne Francia, Tina Lam, Amelia Berg, Kirsty Morgan, Michael Savic, Dan I. Lubman & Suzanne Nielsen. (2023) Alcohol and other drug use: A qualitative exploration of staff and patient's experiences of language use as a means of stigma communication in hospital and primary care settings. Journal of Substance Use and Addiction Treatment 149, pages 209050.
Crossref
Crossref
Carol‐Ann Getty, Tim Weaver & Nicola Metrebian. (2022) A qualitative exploration of patients' experience of mobile telephone‐delivered contingency management to promote adherence to supervised methadone. Drug and Alcohol Review 42:3, pages 641-651.
Crossref
Crossref
Stephanie A. Hooker, A. Lauren Crain, Amy B. LaFrance, Sheryl Kane, J. Konadu Fokuo, Gavin Bart & Rebecca C. Rossom. (2023) A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. Addiction Science & Clinical Practice 18:1.
Crossref
Crossref
Jonathan H. Watanabe. (2023) The Critical Role of Pharmacists in Treating Older People in the Opioid Crisis. The Senior Care Pharmacist 38:2, pages 47-49.
Crossref
Crossref
Marina Gaeta Gazzola, Emma Maclean, Mark Beitel, Iain D. Carmichael, Katharine M. Cammack, Kathryn F. Eggert, Teresa Roehrich, Lynn M. Madden, Oluwole Jegede, Xiaoying Zheng, Emma Bergman & Declan T. Barry. (2022) What’s in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment. Journal of General Internal Medicine 38:3, pages 653-660.
Crossref
Crossref
Victoria Rice Carlisle, Olivia M. Maynard, Darren Bagnall, Matthew Hickman, Jon Shorrock, Kyla Thomas & Joanna Kesten. (2023) Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys. International Journal of Environmental Research and Public Health 20:2, pages 1526.
Crossref
Crossref
Kirsten Marchand, Oonagh Fogarty, Katrina Marie Pellatt, Kayly Vig, Jordan Melnychuk, Christina Katan, Faria Khan, Roxanne Turuba, Linda Kongnetiman, Corinne Tallon, Jill Fairbank, Steve Mathias & Skye Barbic. (2022) “We need to build a better bridge”: findings from a multi-site qualitative analysis of opportunities for improving opioid treatment services for youth. Harm Reduction Journal 19:1.
Crossref
Crossref
Sheryl Spithoff, Lana Mogic, Susan Hum, Rahim Moineddin, Christopher Meaney & Tara Kiran. (2022) Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada. JAMA Network Open 5:9, pages e2233659.
Crossref
Crossref
John R. Brooklyn, Marne Stothart, Mallory Stunell, Vanessa Melamede Berman, Danielle Rylant & Melanie Hanson. (2022) Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment. Journal of Addiction Medicine 16:3, pages 310-316.
Crossref
Crossref
Kathryn J. LaRoche, Ariane Wylie, Mira Persaud & Angel M. Foster. (2022) Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project. Contraception 109, pages 37-42.
Crossref
Crossref
Josefine Skou Jakobsen, Malene Lindgaard Kloster, Louise Christensen, Katrine Schepelern Johansen, Nanna Kappel, Mette Kronbæk, Kristian Relsted Fahnøe & Esben Houborg. (2021) Trade-offs in Substitution Treatment: A Qualitative Study of an Opioid Substitution Therapy Clinic as an Enabling and a Risk-Environment. Contemporary Drug Problems 49:1, pages 64-83.
Crossref
Crossref
Li‐Tzy Wu, William S. John, Eric D. Morse, Steve Adkins, Jennifer Pippin, Robert K. Brooner & Robert P. Schwartz. (2021) Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial. Addiction 117:2, pages 444-456.
Crossref
Crossref
Kirsten Marchand, Heather Palis, Daphne Guh, Kurt Lock, Scott MacDonald, Suzanne Brissette, David C. Marsh, Scott Harrison, Martin T. Schechter & Eugenia Oviedo-Joekes. (2022) A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research. Journal of Substance Abuse Treatment 132, pages 108512.
Crossref
Crossref
Siv-Elin Leirvaag Carlsen, Katja Isaksen, Lars Thore Fadnes, Ole Jørgen Scheie Lygren & Anne Nordrehaug Åstrøm. (2021) Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals’ experiences. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Anthony Barnett, Michael Savic, Nicholas Lintzeris, Ramez Bathish, Shalini Arunogiri, Adrian J. Dunlop, Paul Haber, Robert Graham, Vicky Hayes & Dan I. Lubman. (2021) Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia. Drug and Alcohol Dependence 227, pages 108959.
Crossref
Crossref
Tejaswini Patil, Jane Mummery, Mohammed Salman, Simon Cooper & Dominic Williams. (2021) “Before the training I just assumed they've done something bad”: Reporting on professional training for pharmacy assistants and pharmacy dispensary technicians on medically assisted treatment of opioid dependence. Research in Social and Administrative Pharmacy 17:7, pages 1250-1258.
Crossref
Crossref
Tony Antoniou, Cheryl Pritlove, Dana Shearer, Diana Martins, Mina Tadrous, Charlotte Munro & Tara Gomes. (2021) A qualitative study of a publicly funded pharmacy-dispensed naloxone program. International Journal of Drug Policy 92, pages 103146.
Crossref
Crossref
Bruce Wallace, Karen MacKinnon, Heather Strosher, Celeste Macevicius, Carol Gordon, Rebecca Raworth, Lacey Mesley, Sana Shahram, Lenora Marcellus, Karen Urbanoski & Bernadette Pauly. (2021) Equity-oriented frameworks to inform responses to opioid overdoses: a scoping review. JBI Evidence Synthesis 19:8, pages 1760-1843.
Crossref
Crossref
Kirsten Marchand, Julie Foreman, Scott MacDonald, Scott Harrison, Martin T. Schechter & Eugenia Oviedo-Joekes. (2020) Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment. Substance Abuse Treatment, Prevention, and Policy 15:1.
Crossref
Crossref
Harry Jin, Brandon D. L. Marshall, Louisa Degenhardt, John Strang, Matt Hickman, David A. Fiellin, Robert Ali, Julie Bruneau & Sarah Larney. (2020) Global opioid agonist treatment: a review of clinical practices by country. Addiction 115:12, pages 2243-2254.
Crossref
Crossref
Katharine Cioe, Breanne E. Biondi, Rebecca Easly, Amanda Simard, Xiao Zheng & Sandra A. Springer. (2020) A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder. Journal of Substance Abuse Treatment 119, pages 108146.
Crossref
Crossref
Qijian Deng, Maorong Hu, Fang Yu, Qiaosheng Liu, Wei Hao, Qiuxia Wu & Tao Luo. (2020) A Community-Based Investigation of Stigma Toward Individuals Receiving Methadone Maintenance Treatment in China: A Randomized Case Vignette Study. Frontiers in Psychiatry 11.
Crossref
Crossref
Tony Antoniou, Daniel McCormack, Tonya Campbell, Rinku Sutradhar, Mina Tadrous, Nancy Lum-Wilson, Pamela Leece, Charlotte Munro & Tara Gomes. (2020) Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis. Drug and Alcohol Dependence 216, pages 108238.
Crossref
Crossref
Ana Rodas, Melanie Simpson, Paddy Rawlinson, Ronald Kramer, Emma Ryan, Emmeline Taylor, Reece Walters, Alan Beckley, Chris Cunneen, Ashlee Gore, Amanda Porter, Scott Poynting & Emma RussellMelanie Simpson. 2020. Crime, Deviance and Society. Crime, Deviance and Society
128
148
.
Julia Dickson-Gomez, Wamala Twaibu, Erica Christenson, Katende Dan, Ronald Anguzu, Ethan Homedi & Nazarius Mbona Tumwesigye. (2020) Injection and sexual risk among people who use or inject drugs in Kampala, Uganda: An exploratory qualitative study. PLOS ONE 15:4, pages e0231969.
Crossref
Crossref
George Pro & Nick Zaller. (2020) Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings. PLOS ONE 15:2, pages e0228755.
Crossref
Crossref
Hege Solberg & Dagfinn Nåden. (2019) It is just that people treat you like a human being: The meaning of dignity for patients with substance use disorders. Journal of Clinical Nursing 29:3-4, pages 480-491.
Crossref
Crossref
Laramie R. Smith, Maria Luisa Mittal, Karla Wagner, Michael M. Copenhaver, Chinazo O. Cunningham & Valerie A. Earnshaw. (2019) Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT‐SMS). Addiction 115:2, pages 354-367.
Crossref
Crossref
Melissa D. McCradden, Denitsa Vasileva, Ani Orchanian-Cheff & Daniel Z. Buchman. (2019) Ambiguous identities of drugs and people: A scoping review of opioid-related stigma. International Journal of Drug Policy 74, pages 205-215.
Crossref
Crossref
Catalina N. Rey, Allison N. Kurti, Gary J. Badger, Alex H. Cohen & Sarah H. Heil. (2019) Stigma, Discrimination, Treatment Effectiveness, and Policy Support: Comparing Behavior Analysts’ Views on Drug Addiction and Mental Illness. Behavior Analysis in Practice 12:4, pages 758-766.
Crossref
Crossref
Lindsay Fox & Lewis S. Nelson. (2019) Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential. CNS Drugs 33:12, pages 1147-1154.
Crossref
Crossref
Valerie A. Earnshaw, Laura M. Bogart, David D. Menino, John F. Kelly, Stephenie R. Chaudoir, Natalie M. Reed & Sharon Levy. (2018) Disclosure, Stigma, and Social Support Among Young People Receiving Treatment for Substance Use Disorders and Their Caregivers: a Qualitative Analysis. International Journal of Mental Health and Addiction 17:6, pages 1535-1549.
Crossref
Crossref
Geoffrey Maina, Alexander Crizzle, Sithokozile Maposa & Bonnie Fournier. (2019) Sociodemographic Profiles and Clinical Outcomes for Clients on Methadone Maintenance Treatment in a Western Canadian Clinic: Implications for Practice. Journal of Forensic Nursing 15:4, pages 231-241.
Crossref
Crossref
Courtney Pearson Jeske & Patrick O’Byrne. (2019) Perceptions and Experiences of Methadone Maintenance Treatment. Journal of Addictions Nursing 30:4, pages 248-253.
Crossref
Crossref
Stevie Chancellor, George Nitzburg, Andrea Hu, Francisco Zampieri & Munmun De Choudhury. (2019) Discovering Alternative Treatments for Opioid Use Recovery Using Social Media. Discovering Alternative Treatments for Opioid Use Recovery Using Social Media.
Patrick O'Byrne & Courtney Jeske Pearson. (2018) Methadone maintenance treatment as social control: Analyzing patient experiences. Nursing Inquiry 26:2, pages e12275.
Crossref
Crossref
Heather Stuart. (2019) Managing the stigma of opioid use. Healthcare Management Forum 32:2, pages 78-83.
Crossref
Crossref
Patrick W. Corrigan & Katherine Nieweglowski. (2018) Stigma and the public health agenda for the opioid crisis in America. International Journal of Drug Policy 59, pages 44-49.
Crossref
Crossref
Milad Parpouchi, Akm Moniruzzaman, Stefanie N. Rezansoff, Angela Russolillo & Julian M. Somers. (2018) The effect of Housing First on adherence to methadone maintenance treatment. International Journal of Drug Policy 56, pages 73-80.
Crossref
Crossref
Sasha Cooper, Gabrielle Campbell, Briony Larance, Bridin Murnion & Suzanne Nielsen. (2018) Perceived stigma and social support in treatment for pharmaceutical opioid dependence. Drug and Alcohol Review 37:2, pages 262-272.
Crossref
Crossref
Phuong-Phi Le, Annette Braunack-Mayer & Caroline Laurence. (2018) Collaborative pharmacist prescribing within the opioid substitution treatment program in South Australia: Patient and pharmacist views. Research in Social and Administrative Pharmacy 14:2, pages 187-195.
Crossref
Crossref
Joseph Fonseca, Andrew Chang & Feng Chang. (2018) Perceived Barriers and Facilitators to Providing Methadone Maintenance Treatment Among Rural Community Pharmacists in Southwestern Ontario. The Journal of Rural Health 34:1, pages 23-30.
Crossref
Crossref
Pollyanna Santos da Silveira, Joanna Gonçalves Andrade de Tostes, Hoi Ting Wan, Telmo Mota Ronzani & Patrick W. Corrigan. 2018. Drugs and Social Context. Drugs and Social Context
15
25
.
Andrew Radley, Karen Melville, Phyllis Easton, Brian Williams & John F Dillon. (2017) ‘Standing Outside the Junkie Door’—service users’ experiences of using community pharmacies to access treatment for opioid dependency. Journal of Public Health 39:4, pages 846-855.
Crossref
Crossref
Ogbonna Brian. (2017) Community Pharmacists and Health Promotion Activities in the 21st Century; Maximizing the Expanded Roles for Universal Health Coverage and Population Health Optimization. MOJ Public Health 6:3.
Crossref
Crossref
Qi Guan, Wayne Khuu, Sheryl Spithoff, Tara Kiran, Meldon Kahan, Mina Tadrous, Diana Martins, Pamela Leece & Tara Gomes. (2017) Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. Drug and Alcohol Dependence 177, pages 315-321.
Crossref
Crossref
Suzanne Fraser, Kiran Pienaar, Ella Dilkes-Frayne, David Moore, Renata Kokanovic, Carla Treloar & Adrian Dunlop. (2017) Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis. International Journal of Drug Policy 44, pages 192-201.
Crossref
Crossref
Justyna Klingemann. (2017) The rights of drug treatment patients: Experience of addiction treatment in Poland from a human rights perspective. International Journal of Drug Policy 43, pages 67-73.
Crossref
Crossref
Sasha Cooper & Suzanne Nielsen. (2016) Stigma and Social Support in Pharmaceutical Opioid Treatment Populations: a Scoping Review. International Journal of Mental Health and Addiction 15:2, pages 452-469.
Crossref
Crossref
Julia Woo, Anuja Bhalerao, Monica Bawor, Meha Bhatt, Brittany Dennis, Natalia Mouravska, Laura Zielinski & Zainab Samaan. (2017) “Don’t Judge a Book by Its Cover”: A Qualitative Study of Methadone Patients’ Experiences of Stigma. Substance Abuse: Research and Treatment 11, pages 117822181668508.
Crossref
Crossref
Andrea L. Murphy, Ruth Martin-Misener, Stan P. Kutcher, Claire L. O’Reilly, Timothy F. Chen & David M. Gardner. (2016) From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies. BMC Health Services Research 16:1.
Crossref
Crossref
Bach Xuan Tran, Phuong Bich Vu, Long Hoang Nguyen, Sophia Knowlton Latkin, Cuong Tat Nguyen, Huong Thu Thi Phan & Carl A. Latkin. (2016) Drug addiction stigma in relation to methadone maintenance treatment by different service delivery models in Vietnam. BMC Public Health 16:1.
Crossref
Crossref
Katrina Warren, Suzanne Huot, Lilian Magalhães & Marilyn Evans. (2016) Exploring the Daily Lives of People on Methadone Maintenance Treatment: An Occupational Perspective. Societies 6:3, pages 27.
Crossref
Crossref
Amanda Laird, Carole Hunter, Colette Montgomery Sardar, Niamh M. Fitzgerald & Richard Lowrie. (2016) Community pharmacy-based opiate substitution treatment and related health services: a study of 508 patients and 111 pharmacies. Journal of Public Health 24:3, pages 193-207.
Crossref
Crossref
J. Mitchell Miller, O. Hayden GriffinIIIIII & Courtney Marciá Gardner. (2016) Opiate treatment in the criminal justice system: a review of crimesolutions.gov evidence rated programs. American Journal of Criminal Justice 41:1, pages 70-82.
Crossref
Crossref
Christina Brezing & David Marcovitz. 2016. Stigma and Prejudice. Stigma and Prejudice
113
132
.
Karen R. Flórez, Kathryn Pitkin Derose, Joshua Breslau, Beth Ann Griffin, Ann C. Haas, David E. Kanouse, Brian D. Stucky & Malcolm V. Williams. (2015) Acculturation and Drug Use Stigma Among Latinos and African Americans: An Examination of a Church-Based Sample. Journal of Immigrant and Minority Health 17:6, pages 1607-1614.
Crossref
Crossref
Lynda Berends, Jenny Chalmers & Kari Lancaster. (2015) Trust, agency and control: Perspectives on methadone takeaway dosing in the context of the Victorian policy review. Drug and Alcohol Review 34:5, pages 483-486.
Crossref
Crossref
Ryan McNeil, Thomas Kerr, Solanna Anderson, Lisa Maher, Chereece Keewatin, M.J. Milloy, Evan Wood & Will Small. (2015) Negotiating structural vulnerability following regulatory changes to a provincial methadone program in vancouver, canada: A qualitative study. Social Science & Medicine 133, pages 168-176.
Crossref
Crossref
Lydia Turner, Stefan P. Kruszewski & G. Caleb Alexander. (2015) Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013. The American Journal on Addictions 24:1, pages 24-29.
Crossref
Crossref
Gabi Koller. (2014)
Commentary on Holland
et al
. (2014): Opioid maintenance treatment-how much supervision is helpful?
. Addiction 109:4, pages 608-609.
Crossref
Crossref
Caitlin Notley, Richard Holland, Vivienne Maskrey, Jessica Nagar & Christos Kouimtsidis. (2014) Regaining control: The patient experience of supervised compared with unsupervised consumption in opiate substitution treatment. Drug and Alcohol Review 33:1, pages 64-70.
Crossref
Crossref
Neil McKeganeyNeil McKeganey. 2014. A–Z of Substance Misuse and Drug Addiction. A–Z of Substance Misuse and Drug Addiction
160
180
.
Polly Radcliffe & Tessa Parkes. (2013) The politics of providing opioid pharmacotherapy. International Journal of Drug Policy 24:6, pages e6-e10.
Crossref
Crossref
Joanne Neale. (2013) Opioid pharmacotherapy: Treatment, regimes, constructions and control. International Journal of Drug Policy 24:6, pages e1-e5.
Crossref
Crossref
Hanna Uosukainen, J. Simon Bell, Kirsti Laitinen, Ulrich Tacke, Jenni Ilomäki & Juha H.O. Turunen. (2013) First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland. International Journal of Drug Policy 24:5, pages 492-497.
Crossref
Crossref
Hanna Uosukainen, Hannu Pentikäinen & Ulrich Tacke. (2013) The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone—experience from a medium-sized Finnish city. Journal of Substance Abuse Treatment 45:1, pages 143-147.
Crossref
Crossref
Valerie Earnshaw, Laramie Smith & Michael Copenhaver. (2012) Drug Addiction Stigma in the Context of Methadone Maintenance Therapy: An Investigation into Understudied Sources of Stigma. International Journal of Mental Health and Addiction 11:1, pages 110-122.
Crossref
Crossref
Joanne Neale, Sarah Nettleton & Lucy Pickering. (2013) Does recovery-oriented treatment prompt heroin users prematurely into detoxification and abstinence programmes? Qualitative study. Drug and Alcohol Dependence 127:1-3, pages 163-169.
Crossref
Crossref
Amy Irwin, Christianne Laing & Kathryn Mearns. (2012) Dealing with aggressive methadone patients in community pharmacy: A critical incident study. Research in Social and Administrative Pharmacy 8:6, pages 542-551.
Crossref
Crossref
Jean Bonhomme, Ruth S. Shim, Richard Gooden, Dawn Tysu & George Rust. (2012) Opioid Addiction and Abuse in Primary Care Practice: A Comparison of Methadone and Buprenorphine as Treatment Options. Journal of the National Medical Association 104:7-8, pages 342-350.
Crossref
Crossref
Julie Harris & Karen McElrath. (2012) Methadone as Social Control. Qualitative Health Research 22:6, pages 810-824.
Crossref
Crossref
Tyler WatsonChristine Hughes. (2012) Pharmacists and Harm Reduction: A Review of Current Practices and Attitudes. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 145:3, pages 124-127.e2.
Crossref
Crossref
Verena Metz, Birgit Köchl & Gabriele Fischer. (2012) Should pregnant women with substance use disorders be managed differently?. Neuropsychiatry 2:1, pages 29-41.
Crossref
Crossref
James D. Livingston, Teresa Milne, Mei Lan Fang & Erica Amari. (2011) The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction 107:1, pages 39-50.
Crossref
Crossref
Craig L. Fry & Daniel Z. Buchman. 2012. Addiction Neuroethics. Addiction Neuroethics
175
193
.
G. Gerra, E. Saenz, A. Busse, I. Maremmani, R. Ciccocioppo, A. Zaimovic, M.L. Gerra, M. Amore, M. Manfredini, C. Donnini & L. Somaini. (2011) Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:2, pages 483-489.
Crossref
Crossref
Victoria Smye, Annette J Browne, Colleen Varcoe & Viviane Josewski. (2011) Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: An intersectional lens in the Canadian context. Harm Reduction Journal 8:1, pages 17.
Crossref
Crossref
Marcelo F. BatkisGlenn J. TreismanAndrew F. Angelino. (2010) Integrated Opioid Use Disorder and HIV Treatment: Rationale, Clinical Guidelines for Addiction Treatment, and Review of Interactions of Antiretroviral Agents and Opioid Agonist Therapies. AIDS Patient Care and STDs 24:1, pages 15-22.
Crossref
Crossref